Skip to content

Formoterol

Formoterol (Dulera) is used with a controller medicine for asthma and to prevent bronchospasm. This catalogue includes two inhalers, Foracort Inhaler and Dulera, in the same respiratory category.

Medicines containing Formoterol

Foracort Inhaler

Asthma, Chronic Obstructive Pulmonary Disease

100mcg + 6mcg · 200mcg + 6mcg · 400mcg + 6mcg

Formoterol and budesonide inhaler for asthma and COPD. The budesonide reduces swelling while formoterol opens the airways.

From$40.40/ inhalerView

Dulera

Asthma, Chronic Obstructive Pulmonary Disease

6mcg + 200mcg

Mometasone and formoterol inhaler for asthma and COPD. It combines a steroid and a long-acting bronchodilator.

From$68.17/ inhalerView

Key points

  • Asthma-related death: Long-acting beta2-agonists such as formoterol increase this risk; the label treats it as a class effect.
  • Controller medicine: Formoterol must not be used for asthma without a long-term control medicine, such as an inhaled corticosteroid.
  • What remains uncertain: Available data cannot determine whether an inhaled corticosteroid reduces the LABA-related asthma-death risk.

Brands and forms in this catalogue

Both listed inhalers pair formoterol, a long-acting beta2-agonist (LABA), with a corticosteroid. Foracort Inhaler contains budesonide, while Dulera contains mometasone furoate. They are listed for Asthma and Chronic Obstructive Pulmonary Disease, within Respiratory Health.

Further reading